Follow-up of percutaneous transcatheter closure of pulmonary arteriovenous fistulas  

作　　者：Shi-Bing Xi Yu-Mei Xie Ming-Yang Qian Ji-Jun Shi Yi-Fan Li Zhi-Wei Zhang 

机构地区：[1]Department of Pediatric Cardiology,Guangdong Cardiovascular Institute,Guangdong Academy of Medical Science/Guangdong Provincial People's Hospital,Guangzhou,Guangdong 510080,China

出　　处：《Chinese Medical Journal》2019年第8期980-983,共4页中华医学杂志（英文版）

摘　　要：To the Editor:Pulmonary arteriovenous fistula(PAVF)is abnormally dilated vessels that bypass the lung capillary bed,providing a direct right-to-left shunt:.The clinical manifestations of PAVF can vary from asymptomatic to dyspnea on exertion,fatigability,cyanosis,and neurological complications.Patients with congenital PAVF are often associated with hereditary hemorrhagic telangiectasia(HHT)and congenital heart disease.The primary aim of treatment through transcatheter techniques or surgery is to reduce or abrogate abnormal shunt and to prevent severe complications.The development of medical apparatus and instruments has expanded the in dications of interventional closure of PAVF.However,data on the efficacy and safety of transcatheter closure of PAVFs is still lacking.

关 键 词：PERCUTANEOUS TRANSCATHETER closure PULMONARY ARTERIOVENOUS FISTULAS PULMONARY ARTERIOVENOUS fistula(PAVF) 

分 类 号：R[医药卫生]